Terapias secuencia y c onc omitante pa ra e rradicaci ón de Helicobacter pylori - J. Cortés N. et al. Medicina Basada en la evidencia en Gastroenterología 235 Referencias 1.- McNicholl AG, Marín AC, Molina- Infante J, Castro M, Barrio J, Ducons J, et al. Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice. Gut 2014; 63: 244-9. 2.- Hunt RH, Xiao SD, Megraud F, Leon-Barua R, Bazzoli F, van der Merwe S, et al. Helicobacter pylori in developing countries. World Gastroenterology Organization Global Guideline. J Gastrointestin Liver Dis 2011: 20; 299-304. 3.- Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16 Suppl 1: 3-15. 4.- Centers for Disease Control and Prevention, Fact Sheet for Health Care Providers. Helicobacter pylori, July 1998. Disponible en: http://www.cdc.gov/ ulcer/files/hpfacts.PDF Consultado el 19 de abril de 2015. 5.- Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis 2012; 13: 2-9. 6.- Chey W, Wong B, and the Practice Parameters Committee of the American College of Gastroenterology, Management of Helicobacter pylori Infection, 2007. Disponible en: gi.org/ guideline/management-of-helicobacterpylori infection/ Consultado el 19 de abril de 2015. 7.- Fischbach L, Evans EL. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment Pharmacol Ther 2007; 26: 343-57. 8.- Gisbert JP, Calvet X. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough. Aliment Pharmacol Ther 2011; 34: 1255-68. 9.- Zullo A, Vaira D, Vakil N, Hassan C, Gatta L, Ricci C, et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther 2003; 17: 719-26. 10.- Gisbert JP, Calvet X, O’Connor A, Mégraud F, O’Morain CA. Sequential therapy for Helicobacter pylori eradication: a critical review. J Clin Gastroenterol 2010; 44: 313-25. 11.- Kayar Y, Pamukçu Ö, Eroğlu H, Kalkan Erol K, Ilhan A, Kocaman O. Relationship between Helicobacter pylori Infections in Diabetic Patients and Inflammations, Metabolic Syndrome, and Complications. Int J Chronic Dis 2015; 2015: 290128. 12.- Tong JL, Ran ZH, Shen J, Xiao SD. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis. J Clin Pharm Ther 2009; 34: 41-53. 13.- Camargo MC, García A, Riquelme A, Otero W, Camargo CA, Hernández- García T, et al. The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America. Am J Gastroenterol 2014; 109: 485-95. 14.- Rollan A, Arab JP, Camargo MC, Candia R, Harris P, Ferreccio C, et al. Management of Helicobacter pylori infection in Latin America: A Delphi technique-based consensus. World J Gastroenterol 2014; 20: 10969-83. Gastroenterol. latinoam 2016; Vol 27, Nº 4: 231-235
gastro 4
To see the actual publication please follow the link above